Related Experiment Video
Updated: Feb 13, 2026

Echocardiographic Characterization of Left Ventricular Structure, Function, and Coronary Flow in Neonate Mice
Published on: April 7, 2022
Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia:
Piotr Dobrowolski1, Magdalena Januszewicz2,3, Anna Klisiewicz1
1Department of Congenital Heart Diseases.
Objective:
To provide a comprehensive assessment of left ventricle (LV) structure, and function and to detect alterations in cardiac properties in relationship to presence, subtypes and extent of fibromuscular dysplasia (FMD).
Methods:
We studied 144 patients with FMD. The control group consisted of 50 matched individuals. Office and ambulatory blood pressure levels were evaluated. Echocardiography was employed to assess: left ventricular mass index (LVMI), systolic function including speckle tracking echocardiography and diastolic function assessed by mitral flow and tissue Doppler imaging.
Results:
There were no differences in LV morphology and function between patients with FMD and the control group. Among 128 patients with renal FMD, there were no differences in LVMI and LV systolic function between patients with unifocal and multifocal FMD. The patients with multifocal FMD were characterized by lower early diastolic velocity (e') as compared with unifocal FMD and control groups. However, in a multivariate regression model, e' was not independently correlated with FMD. There were no associations between echocardiographic indexes and vascular involvement of FMD. Also, there were no differences in LV morphology and function in patients with significant renal artery stenosis (RAS) compared with patients with history of significant RAS and patients with nonsignificant RAS.
Conclusion:
Our study in contrast to those with atherosclerotic RAS, did not show differences in LV morphology and function between FMD patients and matched controls. Although FMD can result in hypertension and serious vascular complications, there is no proof that it can alter LV regardless of FMD type and its extent.
Insights
Fibromuscular dysplasia (FMD) does not alter left ventricle (LV) structure or function, even with renal artery stenosis. This study found no significant cardiac differences between FMD patients and controls.
Area of Science:
- Cardiology
- Vascular Medicine
- Echocardiography
Background:
- Fibromuscular dysplasia (FMD) is a vascular disease that can lead to hypertension and other complications.
- The impact of FMD on cardiac structure and function, particularly the left ventricle (LV), requires comprehensive assessment.
Purpose of the Study:
- To assess LV structure and function in patients with FMD.
- To identify potential alterations in cardiac properties related to FMD presence, subtypes, and extent.
- To compare cardiac parameters between FMD patients and a matched control group.
Main Methods:
- 144 patients with FMD and 50 controls underwent echocardiography.
- Evaluated left ventricular mass index (LVMI), systolic function (speckle tracking), and diastolic function (mitral flow, tissue Doppler).
- Office and ambulatory blood pressure levels were also assessed.
Main Results:
- No significant differences in LV morphology or function were observed between FMD patients and controls.
- No differences in LVMI or systolic function were found between unifocal and multifocal renal FMD.
- Multifocal FMD showed lower early diastolic velocity (e'), but this was not independently correlated with FMD in multivariate analysis.
Conclusions:
- Unlike atherosclerotic renal artery stenosis, FMD does not appear to alter LV morphology or function.
- Despite potential hypertension and vascular complications, FMD does not demonstrate a direct impact on the left ventricle.
- Further research may explore subtle diastolic function changes in specific FMD subtypes.
More Related Videos
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Microbial Morphologies
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
Serum Studies: Renal Function Tests
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Functional Groups

